home / stock / ctlt / ctlt quote
$116.40 Last:
2.37% Change Percent:
$114.78 Open:
$116.40 Previous Close:
$117.8 High:
$114 Low:
838,443 Volume:
03/01/2021 04:56:19 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-01 | 114.78 | 116.4 | 117.8 | 114 | 838,443 |
2021-02-26 | 112.94 | 113.71 | 114.55 | 111.48 | 983,563 |
2021-02-25 | 114.53 | 112.25 | 115.07 | 111.2 | 1,468,289 |
2021-02-24 | 112.61 | 115.15 | 115.54 | 112.26 | 945,533 |
2021-02-23 | 113.93 | 112.8 | 114 | 109.34 | 1,324,160 |
2021-02-22 | 117.42 | 114.32 | 117.645 | 114.26 | 845,662 |
2021-02-19 | 118.99 | 117.99 | 119.51 | 117.88 | 726,762 |
2021-02-18 | 120.74 | 118.24 | 120.74 | 117.12 | 728,219 |
2021-02-17 | 122 | 120.95 | 122.49 | 119.31 | 575,335 |
2021-02-16 | 125.29 | 122.78 | 127.68 | 122.3 | 1,108,680 |
2021-02-15 | 122.41 | 125.27 | 125.6345 | 122.14 | 744,999 |
2021-02-12 | 122.41 | 125.27 | 125.6345 | 122.14 | 744,993 |
2021-02-11 | 119.94 | 123 | 124.87 | 119.45 | 1,445,229 |
2021-02-10 | 115.17 | 119.22 | 119.92 | 115.09 | 1,148,146 |
2021-02-09 | 113.34 | 114.17 | 116.17 | 113.34 | 914,344 |
2021-02-08 | 114.14 | 113.5 | 114.7 | 112.58 | 606,564 |
2021-02-05 | 113.62 | 113.53 | 114.41 | 111.93 | 878,109 |
2021-02-04 | 113.55 | 113.43 | 114.17 | 112.69 | 725,895 |
2021-02-03 | 118.9 | 113.83 | 119.05 | 112.54 | 1,077,044 |
2021-02-02 | 122.2 | 117.73 | 124.48 | 117.73 | 1,504,309 |
Catalent Inc. Company Name:
CTLT Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will virtually ...
Moderna (NASDAQ: MRNA) has hit a bit of a snag with the manufacturing of its COVID-19 vaccine. The company's fill-and-finish contractor, Catalent (NYSE: CTLT) , is experiencing delays with some of the doses it's responsible for getting out the door. The companies didn't disc...
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its wholly owned subsidiary, ...